CA2673193C - Preparations homogenes de pate et de gel - Google Patents

Preparations homogenes de pate et de gel Download PDF

Info

Publication number
CA2673193C
CA2673193C CA2673193A CA2673193A CA2673193C CA 2673193 C CA2673193 C CA 2673193C CA 2673193 A CA2673193 A CA 2673193A CA 2673193 A CA2673193 A CA 2673193A CA 2673193 C CA2673193 C CA 2673193C
Authority
CA
Canada
Prior art keywords
veterinary
pharmaceutical
paste
paragraph
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2673193A
Other languages
English (en)
Other versions
CA2673193A1 (fr
Inventor
Hassan Nached
Keith Freehauf
Peter Hanson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health USA Inc
Original Assignee
Merial LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2006/048672 external-priority patent/WO2007075827A2/fr
Priority claimed from US11/713,881 external-priority patent/US20080027011A1/en
Application filed by Merial LLC filed Critical Merial LLC
Publication of CA2673193A1 publication Critical patent/CA2673193A1/fr
Application granted granted Critical
Publication of CA2673193C publication Critical patent/CA2673193C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Cette invention concerne une préparation de pâte ou de gel pharmaceutique ou vétérinaire, qui peut comprendre: une quantité efficace d'un agent thérapeutique; éventuellement un absorbant ou un modificateur de viscosité; éventuellement un excipient hydrophile, un colorant, un stabilisant, un surfactif, ou un agent de préservation et éventuellement un antioxydant, un solvant, un aromatisant, un système tampon ou un épaississant; et des méthodes de fabrication de ces préparations. L'invention concerne également, entre autres, des pâtes ou des gels homogènes vétérinaires administrables par voie orale, destinés au traitement, à l'éradication et à la prévention d'infections par les endoparasites et les ectoparasites chez les animaux à sang chaud, tels que les oiseaux, les chevaux et les animaux de compagnie.
CA2673193A 2006-12-19 2007-12-19 Preparations homogenes de pate et de gel Active CA2673193C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
USPCT/US2006/048672 2006-12-19
PCT/US2006/048672 WO2007075827A2 (fr) 2005-12-20 2006-12-19 Formulations de pates homogenes
US11/713,881 US20080027011A1 (en) 2005-12-20 2007-03-05 Homogeneous paste and gel formulations
US11/713,881 2007-03-05
PCT/US2007/088225 WO2008077130A2 (fr) 2006-12-19 2007-12-19 Préparations homogènes de pâte et de gel

Publications (2)

Publication Number Publication Date
CA2673193A1 CA2673193A1 (fr) 2008-06-26
CA2673193C true CA2673193C (fr) 2014-08-05

Family

ID=40984939

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2673193A Active CA2673193C (fr) 2006-12-19 2007-12-19 Preparations homogenes de pate et de gel

Country Status (4)

Country Link
EP (1) EP2101736A4 (fr)
CA (1) CA2673193C (fr)
MX (1) MX2009006656A (fr)
WO (1) WO2008077130A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017310506B2 (en) 2016-08-11 2019-11-21 Dmk Pharmaceuticals Corporation Drug compositions
US11564910B2 (en) 2017-12-08 2023-01-31 Adamis Pharmaceuticals Corporation Drug compositions
JP2021511113A (ja) * 2018-01-18 2021-05-06 ゾエティス・ブルームヒル・アイピー・リミテッド 乾乳牛のウシ乳房炎予防における内部ティートシールおよびその使用
US10857151B1 (en) * 2020-02-21 2020-12-08 Villya LLC Treatment of female genital schistosomiasis
WO2024158694A1 (fr) 2023-01-23 2024-08-02 Villya LLC Compositions et méthodes pour améliorer la solubilité d'agents thérapeutiques du dysfonctionnement érectile

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
AU2004308360B2 (en) * 2003-12-22 2012-02-16 Imrex, Inc. Methods and compositions for oral hygiene
JP5577021B2 (ja) * 2005-02-17 2014-08-20 アボット・ラボラトリーズ 動物における障害を治療および予防するための薬剤組成物の経粘膜投与

Also Published As

Publication number Publication date
WO2008077130A2 (fr) 2008-06-26
MX2009006656A (es) 2009-08-07
EP2101736A4 (fr) 2012-09-19
CA2673193A1 (fr) 2008-06-26
EP2101736A2 (fr) 2009-09-23
WO2008077130A3 (fr) 2008-08-21

Similar Documents

Publication Publication Date Title
US20080027011A1 (en) Homogeneous paste and gel formulations
CA2634394C (fr) Formulations de pates homogenes
ES2743673T3 (es) Composiciones parasiticidas orales veterinarias que comprenden agentes activos de acción sistémica, procedimientos y usos de las mismas
US20170354593A1 (en) Palatable chewable veterinary composition
JP2005533806A (ja) 駆虫性動物用均質経口ペースト
RU2002124584A (ru) Фармацевтические и ветеринарные пастообразные композиции
TWI433691B (zh) 苯并咪唑之非水性組合物
CA2673193C (fr) Preparations homogenes de pate et de gel
KR20200085810A (ko) 주사가능한 이속사졸린 제약 조성물 및 그의 기생충 침입에 대한 용도
ES2366109T3 (es) Formulaciones antihelmínticas.
CN110721152B (zh) 一种治疗动物皮肤寄生虫、真菌感染的缓释组合物
BR112020010291A2 (pt) composição contendo moxidectina para tratamento de infestações de parasitas
AU2007100254B4 (en) Improved parasiticide paste
AU2003238245B2 (en) Anthelmintic oral homogeneous veterinary pastes
BR102013017846A2 (pt) Nanoformulações e submicroformulações com ativos ultraconcentrados com dendrímeros a base de antiespasmódicos e/ou aines (anti-inflamatórios não hormonais) e/ou anti-histamínicos ou aies (anti-inflamatórios hormonais) e/ou ciclosporinas com a finalidade de redimir sintomas de inflamações, cólicas, pruridos e dor em bovinos, suínos, caprinos, ovinos, caninos e felinos ou benzoil uréia e/ou acil uréia e/ou avermectinas isoladamente ou combinada com vermífugo e/ou inseticidas para o controle e prevenção de endo e ectoparasitas em bovinos, suínos, caprinos, ovinos, caninos, felinos e aves

Legal Events

Date Code Title Description
EEER Examination request